These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 36864699)

  • 1. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
    Massin N; Abdennebi I; Porcu-Buisson G; Chevalier N; Descat E; Piétin-Vialle C; Goro S; Brussieux M; Pinto M; Pasquier M; Bry-Gauillard H
    Hum Reprod; 2023 May; 38(5):927-937. PubMed ID: 36864699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with luteal estradiol for programming antagonist cycles compared to no pretreatment in advanced age women stimulated with corifollitropin alfa: a non-inferiority randomized controlled trial.
    Cédrin-Durnerin I; Carton I; Massin N; Chevalier N; Dubourdieu S; Bstandig B; Michelson X; Goro S; Jung C; Guivarc'h-Lévêque A
    Hum Reprod; 2024 Sep; 39(9):1979-1986. PubMed ID: 39008826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does dual oocyte retrieval with continuous FSH administration increase the number of mature oocytes in low responders? An open-label randomized controlled trial.
    Boudry L; Mateizel I; Wouters K; Papaleo E; Mackens S; De Vos M; Racca A; Adriaenssens T; Tournaye H; Blockeel C
    Hum Reprod; 2024 Mar; 39(3):538-547. PubMed ID: 38199789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of endometrial preparation on early pregnancy loss and live birth rate after frozen embryo transfer: a large multicenter cohort study (14 421 frozen cycles).
    Vinsonneau L; Labrosse J; Porcu-Buisson G; Chevalier N; Galey J; Ahdad N; Ayel JP; Rongières C; Bouet PE; Mathieu d'Argent E; Cédrin-Durnerin I; Pessione F; Massin N
    Hum Reprod Open; 2022; 2022(2):hoac007. PubMed ID: 35274060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double versus single stimulation in young low prognosis patients followed by a fresh embryo transfer: a randomized controlled trial (DUOSTIM-fresh).
    Racca A; Rodriguez I; Garcia S; Arroyo G; Polyzos NP
    Hum Reprod; 2024 Jun; ():. PubMed ID: 38845190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
    Bülow NS; Warzecha AK; Nielsen MV; Andersen CY; Holt MD; Petersen MR; Sopa N; Zedeler A; Englund AL; Pinborg A; Grøndahl ML; Skouby SO; Macklon NS
    Hum Reprod; 2023 Nov; 38(11):2154-2165. PubMed ID: 37699851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen and inhibin B levels during ovarian stimulation before and after 8 weeks of low-dose hCG priming in women with low ovarian reserve.
    Friis Wang N; Bogstad JW; Petersen MR; Pinborg A; Yding Andersen C; Løssl K
    Hum Reprod; 2023 Sep; 38(9):1807-1815. PubMed ID: 37354554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.
    Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM; Humaidan P; Alviggi C
    Hum Reprod; 2021 Jul; 36(8):2157-2169. PubMed ID: 34179973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESHRE guideline: ovarian stimulation for IVF/ICSI
    Ovarian Stimulation TEGGO; Bosch E; Broer S; Griesinger G; Grynberg M; Humaidan P; Kolibianakis E; Kunicki M; La Marca A; Lainas G; Le Clef N; Massin N; Mastenbroek S; Polyzos N; Sunkara SK; Timeva T; Töyli M; Urbancsek J; Vermeulen N; Broekmans F
    Hum Reprod Open; 2020; 2020(2):hoaa009. PubMed ID: 32395637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial wellbeing shortly after allocation to a freeze-all strategy compared with a fresh transfer strategy in women and men: a sub-study of a randomized controlled trial.
    Pilegaard SP; Schmidt L; Stormlund S; Koert E; Bogstad JW; Prætorius L; Nielsen HS; la Cour Freiesleben N; Sopa N; Klajnbard A; Humaidan P; Bergh C; Englund ALM; Løssl K; Pinborg A
    Hum Reprod; 2023 Nov; 38(11):2175-2186. PubMed ID: 37742131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
    Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.
    Lobo R; Soerdal T; Ekerhovd E; Cohlen B; Porcu E; Schenk M; Shufaro Y; Smeenk J; Suerdieck MB; Pinton P; Pinborg A;
    Hum Reprod; 2024 May; ():. PubMed ID: 38723189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
    Balkenende EME; Dahhan T; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; Smeenk JMJ; Louwé LA; Cantineau AEP; de Bruin JP; Linn SC; van der Veen F; van Wely M; Goddijn M
    Hum Reprod; 2022 Jul; 37(8):1786-1794. PubMed ID: 35776109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trial.
    Bosch E; Alamá P; Romero JL; Marí M; Labarta E; Pellicer A
    Hum Reprod; 2024 Feb; 39(2):393-402. PubMed ID: 38037188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of blastocyst euploidy rates following luteal versus follicular phase stimulation in a GnRH antagonist protocol: a prospective study with repeated ovarian stimulation cycles.
    Martinez F; Clua E; Roca M; Garcia S; Polyzos NP
    Hum Reprod; 2022 Nov; 37(12):2777-2786. PubMed ID: 36269092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral dydrogesterone versus micronized vaginal progesterone for luteal phase support: a double-blind crossover study investigating pharmacokinetics and impact on the endometrium.
    Loreti S; Thiele K; De Brucker M; Olsen C; Centelles-Lodeiro J; Bourgain C; Waelput W; Tournaye H; Griesinger G; Raes J; Vieira-Silva S; Arck P; Blockeel C; Mackens S
    Hum Reprod; 2024 Feb; 39(2):403-412. PubMed ID: 38110714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian response and embryo ploidy following oral micronized progesterone-primed ovarian stimulation versus GnRH antagonist protocol. A prospective study with repeated ovarian stimulation cycles.
    Vidal MDM; Martínez F; Rodríguez I; Polyzos NP
    Hum Reprod; 2024 May; 39(5):1098-1104. PubMed ID: 38498835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based guideline: unexplained infertility†.
    ; Romualdi D; Ata B; Bhattacharya S; Bosch E; Costello M; Gersak K; Homburg R; Mincheva M; Norman RJ; Piltonen T; Dos Santos-Ribeiro S; Scicluna D; Somers S; Sunkara SK; Verhoeve HR; Le Clef N
    Hum Reprod; 2023 Oct; 38(10):1881-1890. PubMed ID: 37599566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does luteal phase progesterone supplementation affect physical and psychosocial well-being among women undergoing modified natural cycle-FET? A sub-study of a randomized controlled trial.
    Colombo C; Pistoljevic-Kristiansen N; Saupstad M; Bergenheim SJ; Spangmose AL; Klajnbard A; la Cour Freiesleben N; Løkkegaard EC; Englund AL; Husth M; Breth Knudsen U; Alsbjerg B; Prætorius L; Løssl K; Schmidt L; Pinborg A
    Hum Reprod; 2023 Oct; 38(10):1970-1980. PubMed ID: 37634089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A drop in serum progesterone from oocyte pick-up +3 days to +5 days in fresh blastocyst transfer, using hCG-trigger and standard luteal support, is associated with lower ongoing pregnancy rates.
    Uyanik E; Mumusoglu S; Polat M; Yarali Ozbek I; Esteves SC; Humaidan P; Yarali H
    Hum Reprod; 2023 Feb; 38(2):225-236. PubMed ID: 36478179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.